Prot# SEP093-701: Efficacy and Safety of Eslicarbazepine Acetate as First Add-on to Levetiracetam or Lamotrigine Monotherapy or as Later Adjunctive Treatment for Subjects with Uncontrolled Partial-onset Seizures: A Multicenter, Open-label, Non-randomized

Project: Research project

Project Details

StatusFinished
Effective start/end date3/12/18 → 3/12/21

Funding

  • Quintiles, Inc. (Prot# SEP093-701 // Prot# SEP093-701)
  • Sunovion Pharmaceuticals Inc. (Prot# SEP093-701 // Prot# SEP093-701)